Quote: Today, Maimonides Medical Center announced a landmark agreement with MeMed, an Israel-based medical technology firm, for the adoption of MeMed BV, a new, FDA-approved, cutting-edge test that distinguishes whether a patient is suffering from a bacterial or viral infection within 15 minutes.
…The MeMed BV test analyzes the body’s immune response to infection rather than focusing on detecting the presence of a pathogen, yielding reliable results within 15 minutes.
Bull-markets are born on pessimism, grow on skepticism, mature on optimism and die on euphoria .. Sir John Templeton Make your Life a Mission .... NOT an Intermission. † §|PL1|§
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.